Epigenomics and Cancer Risk Factors

Dr. Melanie Weiss

Dr. Melanie Weiss

Dr. Melanie Weiss

Room:

H2.03.063L

Helmholtz Internation Graduate School for Cancer Research

Thesis topic: Functional characterization of lncRNAs in prostate cancer

 

Publication list

  1. García-Domínguez P, Weiss M, Lepore I, Álvarez R, Altucci L, Gronemeyer H, de Lera ÁR. A DNA methyltransferase modulator inspired by peyssonenyne natural product structures. ChemMedChem. 2012; 7: 2101-12. Abstract
  2. Weiss M, Plass C, Gerhauser C. Role of lncRNAs in prostate cancer development and progression. Biol Chem. 2014; 395(11): 1275-90. Abstract

  3. Gu L, Frommel SC, Oakes CC, Simon R, Grupp K, Gerig CY, Bär D, Robinson MD, Baer C, Weiss M, Gu Z, Schapira M, Kuner R, Sültmann H, Provenzano M; ICGC Project on Early Onset Prostate Cancer, Yaspo ML, Brors B, Korbel J, Schlomm T, Sauter G, Eils R, Plass C, Santoro R. BAZ2A (TIP5) is involved in epigenetic alterations in prostate cancer and its overexpression predicts disease recurrence. Nat Genet. 2015; 47(1): 22-30. Abstract

 

to top